105 related articles for article (PubMed ID: 22294598)
21. Regulatory approaches for control of viral contamination of vaccines.
McClenahan S; Uhlenhaut C; Krause PR
PDA J Pharm Sci Technol; 2011; 65(6):557-62. PubMed ID: 22294577
[TBL] [Abstract][Full Text] [Related]
22. Massively parallel sequencing for the detection of adventitious viruses.
Kolman JL
PDA J Pharm Sci Technol; 2011; 65(6):663-7. PubMed ID: 22294594
[TBL] [Abstract][Full Text] [Related]
23. Nanostring's nCounter--A True Digital Target Profiling Technology.
Morrow M; Donaldson J
PDA J Pharm Sci Technol; 2011; 65(6):692. PubMed ID: 22294601
[TBL] [Abstract][Full Text] [Related]
24. Application of Risk Assessments in the Design of the Overall Viral Control Strategy Used during the Manufacture and Testing of Live Virus Vaccines.
Pennathur S
PDA J Pharm Sci Technol; 2011; 65(6):730-6. PubMed ID: 22294607
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a single-platform, rapid, nucleic Acid-based technology for detection of adventitious contaminants of cell culture.
Dehghani H; Lawrence B; Ill RC
PDA J Pharm Sci Technol; 2011; 65(6):675-80. PubMed ID: 22294596
[TBL] [Abstract][Full Text] [Related]
26. Contamination by porcine circovirus type 1: findings, investigations, and learnings.
Piérard I
PDA J Pharm Sci Technol; 2011; 65(6):614. PubMed ID: 22294584
[TBL] [Abstract][Full Text] [Related]
27. Chlorine dioxide remediation of a virus-contaminated manufacturing facility.
Lutgen M
PDA J Pharm Sci Technol; 2011; 65(6):620-4. PubMed ID: 22294587
[TBL] [Abstract][Full Text] [Related]
28. Theory and practice of conventional adventitious virus testing.
Gregersen JP
PDA J Pharm Sci Technol; 2011; 65(6):634-44. PubMed ID: 22294590
[TBL] [Abstract][Full Text] [Related]
29. Detection of adventitious viruses from biologicals using a broad-spectrum microbial detection array.
Jaing C; Gardner S; McLoughlin K; Thissen JB; Slezak T
PDA J Pharm Sci Technol; 2011; 65(6):668-74. PubMed ID: 22294595
[TBL] [Abstract][Full Text] [Related]
30. Adventitious Agents: Issues and Considerations during Pre-Approval Reviews and Inspections.
Eltermann J
PDA J Pharm Sci Technol; 2011; 65(6):694-7. PubMed ID: 22294603
[TBL] [Abstract][Full Text] [Related]
31. Evolution of approaches to viral safety issues for biological products.
Lubiniecki AS
PDA J Pharm Sci Technol; 2011; 65(6):547-56. PubMed ID: 22294576
[TBL] [Abstract][Full Text] [Related]
32. Practicing safe cell culture: applied process designs for minimizing virus contamination risk.
Kiss RD
PDA J Pharm Sci Technol; 2011; 65(6):715-29. PubMed ID: 22294606
[TBL] [Abstract][Full Text] [Related]
33. Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq(R) for the Presence of Porcine Circovirus.
Ranucci CS; Tagmyer T; Duncan P
PDA J Pharm Sci Technol; 2011; 65(6):589-98. PubMed ID: 22294581
[TBL] [Abstract][Full Text] [Related]
34. Broadening our expectations for viral safety risk mitigation.
Kljavin IJ
PDA J Pharm Sci Technol; 2011; 65(6):645-53. PubMed ID: 22294591
[TBL] [Abstract][Full Text] [Related]
35. Risk mitigation strategies for viral contamination of biotechnology products: consideration of best practices.
Rosenberg AS; Cherney B; Brorson K; Clouse K; Kozlowski S; Hughes P; Friedman R
PDA J Pharm Sci Technol; 2011; 65(6):563-7. PubMed ID: 22294578
[TBL] [Abstract][Full Text] [Related]
36. Mouse Minute Virus (MMV) Contamination--A Case Study: Detection, Root Cause Determination, and Corrective Actions.
Moody M; Alves W; Varghese J; Khan F
PDA J Pharm Sci Technol; 2011; 65(6):580-8. PubMed ID: 22294580
[TBL] [Abstract][Full Text] [Related]
37. Proposed algorithm to investigate latent and occult viruses in vaccine cell substrates by chemical induction.
Khan AS; Ma W; Ma Y; Kumar A; Williams DK; Muller J; Ma H; Galvin TA
Biologicals; 2009 Jun; 37(3):196-201. PubMed ID: 19299169
[TBL] [Abstract][Full Text] [Related]
38. Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys.
Ma H; Ma Y; Ma W; Williams DK; Galvin TA; Khan AS
J Virol; 2011 Jul; 85(13):6579-88. PubMed ID: 21543506
[TBL] [Abstract][Full Text] [Related]
39. Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates.
Khan AS; Sears JF
Dev Biol (Basel); 2001; 106():387-92; discussion 392-3. PubMed ID: 11761254
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population.
Fukumoto H; Hishima T; Hasegawa H; Saeki H; Kuroda M; Katano H
Vaccine; 2016 May; 34(24):2700-6. PubMed ID: 27113161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
